Abstract: Molecules containing multiple lanthanide ions have unique potential in applications for medical imaging including the areas of magnetic resonance imaging (MRI) and fluoresence imaging. The study of multilanthanide complexes as contrast agents for MRI and as biologically responsive fluorescent probes has resulted in an improved understanding of the structural characteristics that govern the behavior of these complexes. This review will survey the last five years of progress in multinuclear lanthanide complexes with a specific focus on the structural parameters that impact potential medical imaging applications. The patents cited in this review are from the last five years and describe contrast agents that contain multiple lanthanide ions.
INTRODUCTION
Multimetallic lanthanide (Ln) complexes are widely studied because of their magnetic and luminescent properties. Due to these properties, multilanthanide complexes are potentially useful in nanomedicine, provided the complexes are chemically and kinetically inert, nontoxic, monodisperse, and well characterized. While many multimetallic lanthanide complexes have been studied, few meet all of these requirements [1] [2] [3] [4] . The focus of this review is discrete multilanthanide complexes reported during the last five years that exhibit covalently linked chelates known to bind lanthanide ions tightly (log K GdL > 18). Generally, this category of coordination compounds falls in an intermediate molecular weight range (1-6 kDa) and exhibits relatively short metal-metal distances (<600 nm). Characterization of these discrete complexes allows for structure-function relationships to be definitively analyzed, and these relationships are important for understanding larger systems including polymers and dendrimers [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . The scope of lanthanide-containing materials is too vast to be adequately described in a single review article; consequently, this review will not address dendrimeric, polymeric, or bioconjugated polylanthanide complexes. Reviews for these types of molecules are available elsewhere [1, 4, [22] [23] [24] [25] [26] [27] .
A unique feature of the lanthanides is that the most stable oxidation state for all of these elements is +3, yet they display a wide range of magnetic and luminescent properties over a relatively narrow size range (the +3 ionic radii of elements [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] are in the range of 102-86 pm) [28] . A consequence of these properties is that lanthanide ions tend to form nearly isostructural complexes that commonly exhibit coordination numbers of [8] [9] [10] . From a synthetic perspective, the near-isostructural nature of lanthanides is *Address correspondence to this author at the Department of Chemistry, Wayne State University, 5101 Cass Avenue, Detroit, MI 48202, USA; Tel: 313-577-2070; Fax: 313-577-8822; E-mail: mallen@chem.wayne.edu advantageous because a single ligand can be used to generate lanthanide complexes for a variety of medical applications including magnetic resonance imaging (MRI), optical imaging, and immunogenic assays. With such a wide variety of properties incorporated into almost isostructural elements, ligand design is a key focus for researchers interested in exploring applications of these elements.
Two applications for which multilanthanide complexes are studied include contrast agents for MRI and luminescent imaging probes. This review will cover these two topics with a brief introduction to each topic preceding a detailed discussion of the ligand design and multilanthanide complexes that have been investigated for each application. The article will conclude with a final summary of the contributions made to each field and a discussion of the future potential for this class of complexes.
MULTIMERIC LIGAND DESIGN
A variety of ligand motifs have been used to form multimetallic lanthanide complexes for medical applications. Discussion of the specific syntheses of multimeric ligands is beyond the scope of this article. The techniques employed have been developed in monomeric ligand syntheses that are thoroughly reviewed elsewhere [29] . As a result of the extensive research of monomeric polyamino polycarboxylates, the majority of multimeric ligands are derivatives of the monomeric chelators diethylenetriaminepentaacetic acid (DTPA) and 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) (Fig. 1) . Both DOTA and DTPA form kinetically inert complexes with lanthanides under physiological conditions (k d = 1.2 10 3 and 21 s -1 for GdDTPA and GdDOTA, respectively), and the gadolinium complexes of these ligands are clinically approved contrast agents for MRI [2, 3] . While this review is not focused on monometallic lanthanide complexes, the basic chemistry of these complexes strongly influences the design of ligands for multilanthanide complexes. Thus, a brief discussion of the properties of monomeric complexes will be useful in understanding the design of their multimeric analogs. Most kinetically inert lanthanide complexes contain polydentate chelates with nitrogen-and oxygen-based donors [2, 3] . The majority of these ligands are octadentate, leaving one coordination site for a solvent molecule or other ligand to bind to the metal ion. Two factors contribute to the inertness of these complexes: (1) the chelate effect and (2) electrostatic attraction. Furthermore, macrocyclic-based ligands such as DOTA gain additional stability over their acyclic counterparts due to the macrocyclic effect. Consequently, many multimeric ligands feature macrocyclic chelates, and a common scaffold for these chelates is 1,4,7,10-tetraazacyclododecane (cyclen).
Due to the success of GdDOTA as a contrast agent for MRI, N-functionalized-cyclen-based chelates are common in multilanthanide complexes. Cyclen has been functionalized with a variety of substituents including acetates, amides, phosphonates, alcohols, and ketones [30] [31] [32] [33] . Due to the difference in basicity and nucleophilicity of its four nitrogen atoms, cyclen can be selectively functionalized such that one, two, or three nitrogens remain available for substitution after one substituent is attached [29] . Thus, ligands can be designed in which three substituents serve as donors to the metal center while the remaining substituent covalently links multiple chelating moieties together (for example DO3A, Fig. 2) . The linking substituent is often designed with a donor atom such that eight donors are maintained and the kinetic stability of the chelate is minimally compromised [3] . This popular strategy was demonstrated in early contrast agent research by Tweedle and coworkers with the DO3A synthon [34] . Although macrocyclic chelates are the most popular motifs used in multilanthanide complexes, acyclic chelates offer a different set of structural variations. A common acyclic chelate motif is diethylenetriaminetetraacetic acid (DTTA) (Fig. 2) . Multimeric ligands featuring this motif sometimes require sequential protection and deprotection steps to attach a linking moiety selectively [35] . The kinetic stability of the resulting lanthanide complexes is reduced relative to the parent DTPA complex when the linking moiety does not contain a donor atom, leaving the chelate with only seven metal-binding sites [35] . The reduced stability of seven-coordinate acyclic chelates has limited their use in multilanthanide complexes.
Of equal importance to chelate design is the choice of linking moieties to provide functionality. Linkers are used to determine the number of chelates, control metal-metal distance, rigidify the relative motion of metal ions, interact with analytes, and function as antennas for absorbance and energy transfer. Linker structure and function will be discussed in detail in the following sections.
CONTRAST AGENTS FOR MRI
The first application of multilanthanide systems that this review will describe is contrast agents for MRI, which is an important diagnostic technique for the medical field. Roughly 30% of images acquired in a clinical setting involve the administration of a contrast agent to increase the diagnostic information available from the images [2] . Contrast agents are paramagnetic substances that decrease the longitudinal (T 1 ) and transverse (T 2 ) relaxation times of water protons, thereby increasing contrast in images. Detailed reviews of relaxation theory have been published [3, 36, 37] . With seven unpaired electrons, Gd III is highly paramagnetic and especially well suited for use as a T 1 -shortening contrast agent for MRI. However, Gd III is toxic as the free ion and, therefore, must be chelated in a kinetically inert ligand for use in vivo [38] .
In addition to kinetic inertness, a variety of other parameters can be tuned by changing ligand structure. These parameters ultimately influence a measurable value of contrast-agent efficiency called relaxivity, which has units of mM -1 s -1 . According to the Solomon-Bloembergen-Morgan (SBM) and Freed equations that describe the behavior of T 1 -shortening contrast agents, optimal relaxivity (r 1 ) is achieved when the condition in Equation 1 is satisfied [2, 3] .
In Equation 1 , I is the proton Larmor frequency, 1/ R is the rotational correlation rate, 1/ m is the bound-water exchange rate, and 1/T 1e is the electronic relaxation rate of Gd III . A common magnetic field strength for the study of multilanthanide complexes is 0.47 T, which corresponds to a proton Larmor frequency of 20 MHz, whereas a common clinical field strength is 1.5 T, which corresponds to a Larmor frequency of 64 MHz. While field strength influences relaxivity, the trends that we will elucidate from the studies of multilanthanide complexes are valid at clinical magnetic fields because at either field strength, the sum of 1/ R , 1/ m , and 1/T 1e must be on the order of 10 7 s -1 to achieve maximum relaxivity. Additionally, as magnet technology improves and higher field strengths become available, optimal values of these three parameters will need to be achieved through ligand design. The need to tune the structure of contrast agents for MRI to reach specific values of the three parameters listed above has resulted in decades of studies of monometallic lanthanide chelates, and several detailed reviews have been published on this topic [39] [40] [41] . Due to the multitude of studies focused on the relationship between the structural features of lanthanide chelates and their corresponding ability to function as contrast agents, a functional understanding of the effects of molecular structure on 1/ R , 1/ m , and, to a lesser degree, 1/T 1e has been developed. We will now discuss the relationships between these parameters and the structure of multilanthanide complexes.
ROTATIONAL CORRELATION RATE
The rotational correlation rate, 1/ R , describes the rotation of the Gd-H vector. Therefore, both the global and local motions of chelates affect the magnitude of 1/ R . The local component of 1/ R has been referred to as 1/ lO or 1/ R * and has been analyzed as a separate component from the global 1/ R with the LipariSazbo method [35, 42, 43] . While higher molecular weights result in slower values of 1/ R for monometallic chelates, this relationship is essentially nonexistent for multilanthanide complexes of intermediate molecular weight such as those shown in Fig. (3a, b) . Studies on the behavior of intermediate to high molecular weight compounds with multiple lanthanide chelates indicate that the local motion of one chelate relative to another limits the degree to which a high molecular weight can decrease 1/ R . An early study demonstrated the influence of local motion on 1/ R and relaxivity using a cyclic moiety to bridge two DO3A-type chelates (Fig. 4) [34] . Relative to the more flexible linker on complex 24, a slightly higher relaxivity was achieved with 25. However, inspection of molecular structure reveals that even the cyclic-linked structure retains some degree of freedom between chelates due to potential ring inversion suggesting that even more rigidity is needed in linker design.
Analysis of recently reported dimetallic complexes also reveals that 1/ R is not strictly dependent on molecular weight. Of the 23 complexes presented in this review, only 14 were reported with 1/ R values calculated by fitting nuclear magnetic resonance dispersion (NMRD) data at 298 K. (Values of 1/ R determined using 17 O-NMR spectroscopy cannot be directly compared to NMRD-derived values because the 17 O-NMR technique assesses 1/ R of the Gd-O vector, which is different than 1/ R of the Gd-H vector that is assessed using NMRD data.) Plotting 1/ R for these complexes against molecular weight reveals no apparent relationship ( Fig. 5) [35, [44] [45] [46] [47] [48] [49] [50] . The lack of a correlation between 1/ R and molecular weight may be due in part to the narrow molecular weight range (1100-6000 Da) of this class of compounds, but it is also attributable to the lack of a quantitative model to predict the degree to which the local motion of the chelates contributes to 1/ R . For instance, inspection of 2 and 3 suggests that steric repulsion between the chelates in 3 should restrict the local motion of the chelates relative to the chelates in 2 [45] . Therefore, 1/ R might be expected to be slower for 3 than 2 due to a slower 1/ R * . However, 1/ R is 36% slower for 2 than it is for 3. The reason behind this apparent disagreement may be that the hydrodynamic radius of 2 is slightly larger than that of 3 due to para-versus meta-substitution of the linker. In cases where the hydrodynamic radius can be regarded as similar, such as for 3 and 4, the molecular weight appears to correlate inversely with 1/ R .
Complexes 5-7 also show an inverse correlation between 1/ R and molecular weight [46] . In this case, 1/ R and relaxivity both follow the expected trends of decreasing and increasing, respectively, with increasing molecular weight. Although the authors refer to the rigidity of the structure of 6 relative to 5 as an explanation for its slower 1/ R and higher relaxivity, it is important to note that 6 also has the highest molecular weight of the three similar complexes [46] . The influence of molecular weight on 1/ R was not of particular interest to the study, which focused on Ca II binding, but demonstrates the combined effect of rigidity and molecular weight on 1/ R in multimetallic species. The lessons learned from studying multilanthanide complexes indicate that the rigidity of macromolecular structure is paramount to achieving maximum relaxivity; however, in spite of a qualitative understanding of the value of 1/ R , 1/ R for new multilanthanide complexes is difficult to estimate. Further fundamental studies exploring the modulation of 1/ R and 1/ R * are necessary to enable rational improvements to the design of multilanthanide and macromolecular complexes as contrast agents for MRI. These improvements include the use of ultra-high-field magnets that generate higher resolution images in shorter scan times, properties that are likely to improve clinical diagnosis.
WATER-EXCHANGE RATE
Water-exchange-rate, 1/ m , is usually not the limiting factor in relaxivity for low to intermediate molecular weight contrast agents. However, 1/ m becomes limiting as magnetic field strength increases, and 1/ m will need to be modulated to generate effective contrast agents at ultra-high magnetic field strengths ( 7 T). Methods of modulating 1/ m include changing ligand basicity or changing the number of coordinating atoms [54] [55] [56] . More basic chelates decrease Lewis acidity of coordinated lanthanide ions, which in turn results in weaker water-lanthanide interactions and a concomitant increase in 1/ m . Also, complexes formed from heptacoordinate chelates typically exhibit a faster 1/ m than complexes formed with octadentate chelates, consistent with an associative water-exchange mechanism allowed by the second available coordination site. As a point of reference, 1/ m values for GdDOTA and GdDTPA are 4.1 10 6 s -1 and 3.3 10 6 s -1 , respectively, an order of magnitude slower than optimal at 0.47 T and even less optimal at higher fields [57] . Therefore, a faster 1/ m is desirable regardless of field strength. Values of 1/ m are especially important for higher molecular weight complexes where 1/ R is near an optimal value and 1/ m begins to be the limiting factor in optimizing relaxivity.
The charge and denticity of a chelate are the primary structural features that affect 1/ m . As many synthetic strategies have centered upon DO3A-or DTTA-type chelating moieties, the charge of the ligand is typically only determined by the charges of the substituents on the cyclen or ethylene triamine backbone. Consequently, many multimeric ligands carry three acetate groups per Gd III ion to form neutral complexes. (3a) . Multilanthanide complexes studied for use as contrast agents for MRI reported since 2006. Due to a lack of data necessary for comparison to other complexes described in this article, complex 10 is not discussed in the text [51] . Coordinated water molecules have been omitted for clarity.
An alternative method to increase 1/ m is to sterically crowd the water-binding site [54] [55] [56] . Designing a ligand that introduces steric interference without eliminating the coordinated water molecule is a challenging task. As a result, little research has been conducted with an aim to modulate water exchange in multilanthanide complexes, although several multilanthanide complexes exhibit a faster water exchange rate compared to their monometallic counterparts. For instance, 1 exhibits a nearly optimal 1/ m value of 1.9 10 7 s -1 at 0.47 T where I is 2.0 10 7 s -1 [44] . Complexes 3, 4, 7, and 15 have 1/ m values roughly an order of magnitude closer to I than GdDOTA [45, 46, 49] . The faster 1/ m for 3, 4, 7, and 15 can be attributed to the associative exchange mechanism induced by the heptacoordinate chelates and is probably not due to steric crowding. However, the steric effect of packing several chelates close together is evidenced by the hydration number, q, of these complexes. Rather than the expected q = 2, heptacoordinate chelates 3, 4, and 7 are monohydrated at each lanthanide [45, 46] .
Conversely, complexes 8, 9, 11, and 12 have slower exchange rates than GdDOTA and GdDTPA which can be attributed to the substitution of an acetate with an amide attached to the linker [47, 48] . Therefore, the Lewis acidity of Gd III in these complexes is likely greater compared to tetra-or pentaacetate analogues, leading to stronger waterGd interactions. However, the Lewis acidity of the Gd III ions is not the only factor affecting the water-exchange rates observed for multilanthanide complexes. Fig. (3a, b) .
Complex 13 is a unique example of a multilanthanide complex that contains three DTTA-based chelates [35] . Surprisingly, the water-exchange rate for 13 ( In general, a challenge associated with directly studying water exchange in multilanthanide complexes is the complexity of synthesizing multimeric ligands. However, comparison of 1/ m to I at higher magnetic fields reveals that 1/ m may become limiting for many multilanthanide complexes [2, 3] . Further, the relaxivity of macromolecular systems with 1/ R approaching I will be limited by 1/ m indicating a need to optimize 1/ m in these larger systems; therefore, there is a need in contrast agent research to address 1/ m modulation in multilanthanide systems.
Gd III ELECTRONIC RELAXATION RATE
The potential of multilanthanide complexes to be used as contrast agents for MRI should be discussed noting that changes in electronic relaxation rate, 1/T 1e , have been observed in multilanthanide complexes [61] [62] [63] . The electronic relaxation rate is typically estimated based on the zero field splitting parameter, 2 , and the electronicrelaxation correlation time, v [64] . Substituting the reported 2 and v values for GdDOTA into Equation 2 [64] , we calculated 1/T 1e for field strengths from 0.5 T to 10 T and plotted these values and I versus field strength (Fig. 6) . Equation 2 is considered to be valid only in the range where
, where s is the electron Larmor frequency and S is the Gd III electron spin (S = 7/2) [64] . Therefore, these values are our best estimate due to the lack of empirical analysis of 1/T 1e outside this range. Comparison of the two functions shows that 1/T 1e is 750% faster than optimum at 1.5 T. While 1/T 1e is an order of magnitude closer to I than 1/ R for the monometallic GdDOTA, 1/T 1e and 1/ R are on the same order of magnitude (10 9 s -1 ) for several multilanthanide complexes. Of the complexes presented in this review, four have 1/T 1e -limited relaxivity based on a comparison of 1/ R , 1/ m , and 1/T 1e values. It is likely that 1/T 1e is also limiting for higher molecular weight complexes. While the need to understand and manipulate 1/T 1e is apparent, studies of monometallic Gd III -containing complexes to determine structural features that influence electronic relaxation have been inconclusive. Interestingly, the study of multilanthanide complexes could contribute to the improvement of contrast agents through increasing our understanding of 1/T 1e .
Equation 2
Previous reports describing multilanthanide complexes have suggested a dipolar relaxation mechanism as an explanation for shorter 1/T 1e values in multimetallic systems [62, 63] . However, if a dipolar relaxation mechanism is responsible for modulating 1/T 1e in multilanthanide complexes, 1/T 1e will likely depend on Gd-Gd distances and could be studied with a series of identical chelates and variable-length linkers. The results of these studies would enable the rational synthesis of systems with optimized 1/T 1e to fulfill the condition in Equation 1. Currently, the design of macromolecular lanthanide-containing complexes for contrast agents is essentially limited to attempts to optimize 1/ R and 1/ m . Fig. (6) . Plot of I ( ) and 1/T 1e for GdDOTA ( ) over the low to ultra-high magnetic field strength range. The gray bar represents the range of field strengths at which most multilanthanide complexes have been studied up to common clinical field strengths.
Although previous studies of dinuclear complexes 5-7 did not focus on electronic-relaxation rate [46] , we made an effort to elucidate a relationship between the distance separating the chelates (estimated by the number of atoms between Gd ions) and 1/T 1e (calculated from reported 2 and v values and Equation 2). Our choice to compare only complexes 5-7 is based on the similarity in structure of the chelates and linkers. Other complexes were not considered part of the series due to the lack of structural similarity or published data. In complexes 5-7, 1/T 1e decreases from complex 7 (16-atom-separation) to complex 5 (19-atomseparation) to complex 6 (24-atom separation) ( Table 1 ).
The purpose of this observation is not to make conclusions or a quantitative assessment of the data but to present the possibility that, with further study of multimetallic and in particular dimetallic lanthanide complexes, a method to modulate and understand 1/T 1e could be developed. Currently, the absence of empirical data and direct experimental techniques to interrogate 1/T 1e represents a challenging opportunity for exploration. Gaining a fundamental understanding of 1/T 1e is necessary to improve contrast agents for current clinical fields and to understand how effective high-field contrast agents can be synthesized. 
HYDRATION NUMBER
Another important factor in determining relaxivity is the hydration number of the lanthanide, q. According to the SBM equations, q scales directly with r 1 [3] . As mentioned, the disadvantage of chelates with a hydration number greater than one (with a few exceptions [65] ) is that these complexes tend to be kinetically labile and, therefore, toxic. Despite this limitation, researchers have synthesized multilanthanide complexes with linking moieties that do not contribute a coordinating atom, resulting in q = 2 chelates. This design has resulted in some of the highest relaxivity multilanthanide complexes such as 13 (r 1 = 15.70 mM -1 s -1 Gd -1 , 310 K, 0.47 T) [35] . However, these dihydrated metal ions will likely be limited to preclinical studies because of their labile nature.
PARACEST MRI
In the last decade, paramagnetic chemical exchange saturation transfer (PARACEST) agents have been developed for MRI [66] [67] [68] . A PARACEST agent is a molecule that has exchangeable protons (for example alcohols, amides and metal-bound water) that are shifted by a paramagnet. Paramagnetic substances such as lanthanide ions are able to shift some exchangeable protons 100 parts per million (ppm) or more [66] [67] [68] . Detailed reviews on the mechanism of PARACEST and lanthanide-based PARACEST agents are available [66] [67] [68] [69] ; therefore, we will only briefly describe the features of PARACEST agents that are relevant to multilanthanide systems.
PARACEST imaging relies on the exchange of one or more protons from a paramagnetic complex with protons from the bulk water. A PARACEST image is generated by subtracting two maps of bulk-water-peak intensity: a reference map acquired without a presaturation pulse and a map acquired after a presaturation pulse at the resonance frequency of the exchanging protons. The PARACEST image is the difference in bulk-water-peak-intensity between the reference and presaturated maps. Because the PARACEST phenomenon causes a decrease in bulk-water peak intensity, the scale of a PARACEST image represents the degree of bulk-water-peak suppression.
The efficiency of a PARACEST agent is determined by two factors: (1) the proton-exchange rate, k ex , and (2) the difference between the exchanging-proton and bulk-water chemical shifts, [66] [67] [68] [69] . For a paramagnetic substance to effectively transfer saturated protons to the bulk water, k ex should be less than or equal to | | [66] [67] [68] [69] . Therefore, greater differences in chemical shift (large ) allow for faster proton-exchange rates. PARACEST imaging is advantageous compared to T 1 -and T 2 -based MRI because there is no background signal in a PARACEST image. However, like other MR imaging techniques, PARACEST imaging is insensitive and requires a high concentration (mM) of agent to generate satisfactory images. Therefore, an agent with a large number of exchangeable protons is desirable for decreasing the concentration of agent required [70, 71] .
Of reported PARACEST agents, only two dimetallic lanthanide complexes fit the category of complexes described in this review. Complex 26 (Fig. 7) contains 12 amide protons with chemical shifts that are shifted 12 ppm from the bulk water peak [72] . Although this shift is small and partial overlap with the bulk water peak exists, a PARACEST effect was observed to reduce the bulk water signal by 30% for a 10 mM solution of complex 26 [72] . With complex 27, PARACEST is due to the exchange of coordinated and bulk water molecules (Fig. 7) [73] . The chemical shift of the coordinated water protons is shifted 45 ppm from the bulk water signal, and a 30% reduction in the bulk-water signal was observed for a 10 mM solution of complex 27 [73] . This result is similar to the PARACEST effect observed for a Eu III DOTA tetra(amide) mononuclear analog [29] , indicating that the effect is not augmented by the presence of the second chelate. A potentially more useful molecule may contain two covalently linked amide-based chelates and, therefore, double the number of exchanging water molecules. These preliminary successes of multilanthanide complexes as PARACEST agents provide proof-of-concept that this class of complexes can be used as PARACEST agents. Further exploration of ligands designed to have more highly shifted exchangeable proton peaks is an important direction of future research in this field. Additionally, water exchange in some multilanthanide complexes has been shown to be slower than their monometallic counterparts studied for T 1 -based MRI. Thus, we expect that these ligands could be useful for making PARACEST agents with lanthanides other than Gd III . The use of these multimeric ligands in PARACEST agents has not been reported, but the water-exchange rates reported for their Gd III complexes indicate that their complexes with other lanthanides could be useful as PARACEST contrast agents for MRI. Studies of multilanthanide systems will likely lead to an understanding of how a sufficient chemical shift of a large number of exchangeable protons can be achieved. This understanding has the potential to be applied to macromolecules that contain many exchangeable protons and, therefore, produce highly sensitive PARACEST contrast agents.
MULTILANTHANIDE-BASED LUMINESCENT PROBES
While lanthanides other than Gd III are used in PARACEST imaging, they also lend themselves to optical imaging. Lanthanides exhibit luminescent behavior that results from 4f electronic transitions [74] . These transitions are Laporte forbidden and result in narrow, low intensity emission bands compared to organic fluorophores. The narrow line width of lanthanide emission peaks generates characteristic emission spectra that enable identification of lanthanide-based probes. Additionally, the lifetimes of lanthanide emissions can be on the order of micro-to milliseconds, much longer than organic molecules including biomolecules [74] [75] [76] [77] [78] [79] . These exceptionally long luminescence lifetimes are the key advantage to lanthanidebased probes for medical applications [74] [75] [76] [77] [78] [79] . Background autofluorescence from organic biomolecules decays much faster than lanthanide luminescence such that a delay between excitation and detection in an imaging experiment will eliminate non-lanthanide-based background fluorescence. The possibility that zero-background images could be acquired using luminescent lanthanide probes makes their study a worthwhile pursuit to the medical field. Luminescent lanthanide complexes that are responsive to medically relevant biochemical events could become useful diagnostic probes based on specific molecular-level interactions. Probes based on these interactions have the potential to improve the precision, accuracy, and ease-of-use of diagnostic assays. Further, use of kinetically inert complexes such as those discussed in this review might allow diagnoses in vivo.
Multilanthanide complexes with Eu and Tb have been studied due to their long luminescence lifetimes (110 to 400 μs) and their intense emission bands (relative to other lanthanides) in the visible region. For in vivo imaging emission in the visible region may be viewed as a limitation due to minimal tissue penetration of emitted wavelengths that require invasive detection methods. Yb III complexes emitting in the near-IR region have also been reported to address the issue of improving the tissue depth at which luminescence can be detected [80] . However, due to the similar coordination chemistry throughout the lanthanide series, the study of Eu and Tb complexes is necessary to determine many structural parameters and provide proof-ofconcept for detecting a response. Other lanthanides are typically not strong emitters and have not been reported multilanthanide complexes for these applications, presumably for this reason.
LIGAND DESIGN
Although considerations to prevent lanthanide toxicity using polydentate chelates are necessary for luminescent probes, three other factors also must be considered for the design of multilanthanide complexes for luminescencerelated applications. First, OH and NH oscillators are efficient quenchers of Ln luminescence; therefore, to preserve long Ln luminescent lifetimes, polydentate chelates must not contain OH or NH oscillators in the inner coordination sphere of the metal ion [75] [76] [77] 81] . Second, the low quantum efficiency of Ln ions can be improved with ligands containing organic fluorophores (antennas) that absorb and transfer energy to Ln excited states [75-77, 81, 82] . Third, without interactions with substrates, luminescent lanthanide complexes have little use in medicine; therefore, ideally, the emission intensity or wavelength will change upon the interaction of a substrate with the complex. Ln ions are strong Lewis acids and are capable of binding to a wide variety of anions; however, useful sensing applications require that binding be specific, which requires control of the Ln coordination sphere through judiciously designed ligands. Alternatively, a complex can be designed to bind to an analyte of interest and detection can take place after unbound complex has been washed or diffused away. This strategy has not been reported for multilanthanide systems and represents an unexplored area of future research.
The synthesis of multimeric ligands tends to be more challenging than the synthesis of monomeric ligands; however, the sensitivity of Ln luminescent probes can be increased by a simple additive effect when multiple Ln ions are present in one complex. Another possible advantage of multilanthanide complexes is Ln-sensitized luminescence [80] . In these systems, interactions at each lanthanide can be interrogated separately for ratiometric sensing, wherein the response of the probe can be determined without determining the concentration of the probe [83] . Further, some multilanthanide complexes are known to display different properties than their monometallic analogs such as a response to or cleavage of DNA and RNA for reasons that are not well understood [48, 83, 84] . Yet, while the study of interactions between multilanthanide luminescent probes and DNA is still in its infancy, this class of compounds has the potential to generate useful tools for gene sensing or for therapy in the medical field.
ANTENNAS
Ligands appended with organic fluorophores improve the quantum yield of lanthanide complexes. This improvement is due to more efficient excitation of the chromophore relative to direct excitation of the lanthanide, as illustrated in Fig.  (8) . The specific processes involved in the transfer of energy from the ligand excited state to the lanthanide excited state depend on the relative energies of the donor and acceptor states and detailed reviews of this phenomenon are available elsewhere [75, 77, 78, 81] . Nearly all multilanthanide complexes synthesized for medical sensing applications contain an antenna in the linker (Fig. 9) . Complexes 28 and 30-40 contain aromatic groups that function as antennas within these linkers [83] [84] [85] [86] [87] . The efficiency of energy transfer depends in part on the Ln-antenna distance; therefore, antennas that coordinate to the Ln ion such as the pyridyl ligands in 32 are expected to better sensitize Ln emission than those that transfer energy through space. An additional requirement for the antenna is that the excited energy state must be higher than the Ln excited state and must be sufficiently higher in energy to prevent back energy transfer. Therefore, the antenna excited state should lie at least 1200 cm -1 above the emissive lanthanide excited state [88] . Many conjugated systems other than those shown in Fig. (9) could be used as antennas as long as the excited-state energy level of the antenna is matched to the lanthanide. Due to the wide variety of possible antenna-lanthanide combinations, the study of multilanthanide luminescent probes is expected to expand in the future. Another interesting observation in multilanthanide luminescent probes is that a single fluorophore is capable of sensitizing two Ln ions as demonstrated in complexes 28 and 33-40 [83] [84] [85] . The knowledge gained from studying how multiple lanthanide ions are sensitized by a single antenna is likely to indicate how macromolecular systems can be designed with multiple lanthanide ions excited by a single antenna. This type of design would be advantageous over multipleantenna-containing systems by minimizing the complexity of the macromolecular structure.
LUMINESCENCE SENSING
Adding functionality to multilanthanide complexes brings additional complexity to the design and synthesis of multimeric ligands. The majority of multilanthanide luminescent probes have been synthesized with tetraamide chelates (Fig. 9) . Tetraamide chelates are strong Lewis acids that are potentially useful as anion sensors due to strong binding to negatively charged substrates relative to their neutral counterparts. Dimetallic lanthanide complexes are of particular interest because they have been reported to exhibit different anion-binding characteristics than their monometallic analogs [83, 84] . Sensing anions may be useful in determining ion concentrations, which can be indicators of metabolism and homeostasis in cells, and understanding cellular processes may facilitate identification of cellular abnormalities that could be used to understand and diagnose disease. For example, complexes 28-31 and 33-36 bind anions such as phosphates and dicarboxylates through Lewis acid-Lewis base interactions [83-85, 87, 89] . Alternatively, the sensing of cations, especially toxic species such as Hg II , is of interest for determining contaminant levels in vivo and ex vivo. For this reason, complex 32 was studied, and it was found to show a change in luminescence in the presence of the Hg II cation [86] . The luminescence response is due to the pyridyl groups that leave the Ln coordination sphere to bind to Hg II [86] . Of all substrates that have been studied with multilanthanide complexes, perhaps the most intriguing and potentially useful to the medical field is DNA. Complex 39 was reported to show luminescence changes in the presence of DNA [83] . This exciting result indicates that the development of gene-specific medical assays may be possible. However, how the interaction with DNA is effected by the structural characteristics of complex 39 is not well understood. While further investigation of the interaction of DNA with 39 is underway, studies exploring DNA-binding with new multilanthanide complexes will be useful to elucidate the structural features that are responsible for the DNA interaction.
As mentioned, sensitizing multiple Ln ions using one fluorophore has been demonstrated [83] [84] [85] . While double Ln sensitization is fundamentally interesting, it could be especially useful with heterometallic complexes. Heteromultimetallic complexes would be ideal for ratiometric sensing where one Ln emission remains constant while the others change in response to a substrate. Ratiometric sensing would eliminate the need to know the concentration of the probe, making in vivo analysis of substrates such as cations, anions, and DNA possible where the probe concentration is unknown.
CURRENT & FUTURE DEVELOPMENTS
The study of multilanthanide complexes is a necessary endeavor in pursuit of advanced medical diagnostics. Substantial contributions have been made to the fields of MRI and luminescence imaging by studying multilanthanide complexes. Continued study of these complexes will facilitate our understanding of the fundamental relationship between chemical structure and imaging properties. This knowledge is needed to enable the rational design of larger (nanoscale) complexes for medical applications. These complexes will likely contribute to the field of medical imaging in the form of ultra-high field contrast agents for MRI, activatable probes for MRI, and luminescent in vivo molecular imaging for personalized medicine.
